Illumina Says EU Comms Underscore FTC Bias Over Grail
Illumina Inc. says the Federal Trade Commission improperly coordinated with its European counterparts to derail the company's $8 billion reacquisition of cancer-testing outfit Grail Inc. and wants documentation of the enforcers'...To view the full article, register now.
Already a subscriber? Click here to view full article